Antibiotic-resistant Escherichia coli are common causative agents of human urinary tract infections. Organotin compounds (OTCs) are man-made chemicals that may affect the renal function of exposed humans and rodents. OTCs are widely recognized as bactericides. However, many environmental and a few clinically relevant bacteria have been found resistant to high concentrations of some OTCs. We examined the susceptibility from 47 E. coli clinical isolates to 12 antibiotics and 5 OTCs. Minimum inhibitory concentrations were determined by the fully automated Sensititre™ ARIS™ 2X system, and E. coli strains were classified as resistant, intermediate resistant, or sensitive, according to the M07-A10 and M100-S26 criteria from the National Committee for Clinical Laboratory Standards. All 47 E. coli strains were susceptible to amikacin but resistant to imipenem and intermediate resistant to ampicillin, cefuroxime, and chloramphenicol. In addition, 26 strains were resistant and 21 intermediate resistant to aztreonam, 24 strains were resistant and 23 intermediate resistant to ceftazidime, 44 strains were intermediate resistant and 3 sensitive to cephalothin, and 43 strains were intermediate resistant and 4 sensitive to ciprofloxacin. Approximately half of the strains were susceptible to cefepime, cefotaxime, and gentamicin. E. coli strains were also found resistant to triphenyltin, tributyltin, dibutyltin, trimethyltin, or dimethyltin at final concentration between 10 μmol/L and 1 mmol/L, during 72-h in vitro culture. However, higher in vitro growth inhibition was induced by these OTCs in the presence of the efflux pump inhibitor carbonyl cyanide-m-chlorophenyl hydrazone, which suggests that efflux pumps contribute to making antibiotic-resistant E. coli also resistant to OTCs.

Departamento de Microbiologia Escuela Nacional de Ciencias Biologicas IPN Prolongacion de Carpio y Plan de Ayala Col Santo Tomas Del Miguel Hidalgo 11340 Mexico City Mexico

Faculty for Higher Education Zaragoza UNAM Mexico City Mexico

General Hospital of Zone 57 Cuautitlán Izcalli Mexico

National School of Biological Sciences IPN Mexico City Mexico

Zobrazit více v PubMed

Environ Sci Pollut Res Int. 2017 Apr;24(10):9159-9173 PubMed

Microbiol Spectr. 2018 Apr;6(2): PubMed

Biocontrol Sci. 2017;22(2):89-96 PubMed

BMC Microbiol. 2009 Jan 29;9:20 PubMed

Front Cell Infect Microbiol. 2017 Jun 08;7:241 PubMed

Ann Glob Health. 2016 Jan-Feb;82(1):10-9 PubMed

J Antimicrob Chemother. 2013 Jul;68(7):1594-600 PubMed

J Clin Microbiol. 1996 Mar;34(3):597-602 PubMed

Bull Environ Contam Toxicol. 2013 May;90(5):626-33 PubMed

Antimicrob Agents Chemother. 2018 Sep 24;62(10): PubMed

BMC Genomics. 2015 Nov 17;16:964 PubMed

J Gen Appl Microbiol. 2013;59(1):39-47 PubMed

Front Endocrinol (Lausanne). 2018 May 22;9:256 PubMed

Environ Sci Technol. 2016 Mar 15;50(6):3193-201 PubMed

J Glob Antimicrob Resist. 2018 Sep;14:90-94 PubMed

Reprod Toxicol. 2013 Apr;36:40-52 PubMed

Microb Ecol. 2018 Jan;75(1):104-112 PubMed

J Chemother. 2018 May;30(3):145-149 PubMed

Rev Argent Microbiol. 2019 Jan - Mar;51(1):39-46 PubMed

Sci Rep. 2018 Jun 12;8(1):8928 PubMed

Environ Microbiol Rep. 2015 Oct;7(5):803-9 PubMed

Toxicol Lett. 2016 Oct 17;260:52-69 PubMed

Trends Microbiol. 2018 Mar;26(3):220-228 PubMed

Mar Pollut Bull. 2015 Dec 15;101(1):280-283 PubMed

Int J Antimicrob Agents. 2017 Aug;50(2):219-226 PubMed

Chemosphere. 2017 Sep;183:339-352 PubMed

Environ Sci Technol. 2017 Jan 3;51(1):570-580 PubMed

BMC Res Notes. 2014 Apr 05;7:215 PubMed

Occup Environ Med. 2013 Aug;70(8):561-7 PubMed

Hum Exp Toxicol. 1999 Oct;18(10):619-24 PubMed

BMC Infect Dis. 2017 Oct 10;17(1):670 PubMed

Environ Health. 2014 Jun 05;13(1):45 PubMed

Expert Opin Drug Metab Toxicol. 2017 Mar;13(3):301-309 PubMed

Am J Nephrol. 1993;13(2):124-8 PubMed

FEMS Microbiol Lett. 2004 Mar 12;232(1):7-14 PubMed

Epidemiol Infect. 2018 Jan;146(1):46-57 PubMed

J Appl Toxicol. 2015 May;35(5):500-7 PubMed

Ecohealth. 2016 Dec;13(4):672-686 PubMed

J Chemother. 2017 Dec;29(sup1):2-9 PubMed